CN Patent
CN102952095A — 一种2-羧酸乙酯-5-溴甲基噻唑的合成方法
Assigned to Cgenetech Suzhou China Co Ltd · Expires 2013-03-06 · 13y expired
What this patent protects
本发明公开了一种2-羧酸乙酯-5-溴甲基噻唑的合成方法,以易得的1,3-二氯丙酮和硫代草氨酸乙酯为原料合成2-羧酸乙酯-5-氯甲基噻唑,然后通过卤素的交换反应得到即得2-羧酸乙酯-5-溴甲基噻唑。
USPTO Abstract
本发明公开了一种2-羧酸乙酯-5-溴甲基噻唑的合成方法,以易得的1,3-二氯丙酮和硫代草氨酸乙酯为原料合成2-羧酸乙酯-5-氯甲基噻唑,然后通过卤素的交换反应得到即得2-羧酸乙酯-5-溴甲基噻唑。
Drugs covered by this patent
- Nubeqa (darolutamide) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.